Miriam Bergeret, MSc, is Today's Clinical Lab's managing editor. Before joining Today's Clinical Lab, Miriam obtained an MSc in laboratory medicine and pathobiology from the University of Toronto and gained valuable laboratory experience as a flow cytometry and cell-sorting specialist at a cancer research center in Toronto, Canada. Miriam went on to study publishing at Toronto Metropolitan University and is an active member of Editors Canada and the Council of Science Editors.
Articles by Miriam Bergeret, MSc
|1 min read
COVID-19 Vaccines Safe in Pregnancy
Research suggests that the vaccines may confer protection to infants born to vaccinated individuals
|1 min read
Mapping Human Cells
A new tool provides an in-depth view of intracellular proteins and how they are organized within human cells
|1 min read
New Test Accurately Distinguishes between Bacterial and Viral Infections
Providing results in 45 minutes, the new test could be used at the point of care to reduce unnecessary antibiotic use
|2 min read
A Comprehensive Atlas of Alzheimer’s Mutations
The atlas of mutations that contribute to Alzheimer’s may help identify patients at high risk of the disease
|1 min read
Universal Germline Screening in Cancer
Does universal genetic screening of patients with solid tumors improve detection of high-risk variants?
|1 min read
Self-Sampling for HPV-Based Cervical Screening
A recent trial in the UK is the first to evaluate self-collection methods for HPV-based cervical cancer screening
|4 min read
An Inside View of Brain Tumors
A new blood test may soon allow clinicians to diagnose brain tumors without surgical biopsy
|1 min read
Clinical Organizations Release SARS-CoV-2 Variant Sequencing Guidelines
The rapid communication provides laboratory professionals with guidance on sequencing COVID-19 variants
|5 min read
How Northeastern University Became a Leader in On-Campus COVID-19 Testing
After building a CLIA-certified lab in six weeks, NU has gone on to complete more than 975,000 COVID-19 tests
|2 min read
A New Way to Target “Undruggable” Proteins
Nanobody-based tool may help researchers design drugs to target “undruggable” proteins involved in chronic diseases
|1 min read
New Highly Sensitive Lyme Disease Test Holds Promise
The new PCR-based test can distinguish between early- and late-stage Lyme disease
|5+ min read
